StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Vertex (VRTX) PT Raised to $576 at Wolfe Research
August 5, 2024 5:19 AM
Wolfe Research analyst Andy Chen raised the price target on Vertex (NASDAQ: VRTX) to $576.00 (from $520.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Barclays Downgrades Vertex (VRTX) to Equalweight
August 5, 2024 3:25 AM
Form 4 VERTEX PHARMACEUTICALS For: Aug 01 Filed by: SACHS BRUCE I
August 2, 2024 4:10 PM
Form 10-Q VERTEX PHARMACEUTICALS For: Jun 30
August 2, 2024 4:03 PM
Vertex (VRTX) PT Raised to $462 at Morgan Stanley
August 2, 2024 9:25 AM
Vertex (VRTX) PT Raised to $535 at Piper Sandler
August 2, 2024 7:45 AM
Vertex (VRTX) PT Raised to $600 at H.C. Wainwright
August 2, 2024 6:46 AM
Vertex (VRTX) PT Raised to $515 at Evercore ISI
August 2, 2024 6:01 AM
Form 4 VERTEX PHARMACEUTICALS For: Jul 30 Filed by: Kewalramani Reshma
August 1, 2024 4:17 PM
Form 8-K VERTEX PHARMACEUTICALS For: Aug 01
August 1, 2024 4:06 PM
Vertex Pharma (VRTX) Misses Q2 EPS by 113c; raises guidance
August 1, 2024 4:05 PM
Vertex Reports Second Quarter 2024 Financial Results
August 1, 2024 4:01 PM
